Revolutionary hyaluronic acid-modified edge-activated spanlastics as a novel approach to boost Hepatoprotective activity of Curcumin: Optimization, biochemical analysis and <i>in-vivo</i> assessment.

Int J Pharm X · 2025 · PMC12617799 · PMID 41245514

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Statistical analysis (One-Way ANOVA) confirmed that the difference in drug release between the Cur-HES formulations and the Curcumin suspension was highly significant at all time points ( p ˂ 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Revolutionary hyaluronic acid-modified edge-activated spanlastics as a novel approach to boost Hepatoprotective activity of Curcumin: Optimization, biochemical analysis and &lt;i&gt;in-vivo&lt;/i&gt; assessment.

The sentences

Revolutionary hyaluronic acid-modified edge-activated spanlastics as a novel approach to boost Hepatoprotective activity of Curcumin: Optimization, biochemical analysis and <i>in-vivo</i> assessment.